Literature DB >> 12469906

Microarray analysis of bone morphogenetic protein, transforming growth factor beta, and activin early response genes during osteoblastic cell differentiation.

Diana S de Jong1, Everardus J J van Zoelen, Susanne Bauerschmidt, Wiebe Olijve, Wilma T Steegenga.   

Abstract

Bone morphogenetic protein (BMP) 2, a member of the transforming growth factor (TGF) beta family, is a potent regulator of osteoblast differentiation. In addition, both TGF-beta and activin A can either induce bone formation or inhibit bone formation depending on cell type and differentiation status. Although much is known about the receptors and intracellular second messengers involved in the action of TGF-beta family members, little is known about how selectivity in the biological response of individual family members is controlled. In this study, we have investigated selective gene induction by BMP-2, TGF-beta1 and activin A in relation to their ability to control differentiation of mouse mesenchymal precursor cells C2C12 into osteoblastic cells. TGF-beta1 can inhibit BMP-2-induced differentiation of these cells, whereas activin A was found to be without morphogenetic effect. Using a gene expression microarray approach covering 8636 sequences, we have identified a total of 57 established genes and expressed sequence tags (ESTs) that were either up-regulated or down-regulated 2 h after treatment with at least one of these three stimuli. With respect to the established genes, 15 new target genes for TGF-beta family members thus were identified. Furthermore, a set of transcripts was identified, which was oppositely regulated by TGF-beta1 and BMP-2. Based on the inverse biological effects of TGF-beta1 and BMP-2 on C2C12 cells, these genes are important candidates for controlling the process of growth factor-induced osteoblast differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12469906     DOI: 10.1359/jbmr.2002.17.12.2119

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  12 in total

1.  BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b.

Authors:  Shoichiro Kokabu; Laura Gamer; Karen Cox; Jonathan Lowery; Kunikazu Tsuji; Regina Raz; Aris Economides; Takenobu Katagiri; Vicki Rosen
Journal:  Mol Endocrinol       Date:  2011-11-10

Review 2.  Bone regeneration by stem cell and tissue engineering in oral and maxillofacial region.

Authors:  Zhiyuan Zhang
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

Review 3.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

4.  Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells.

Authors:  S K Baniwal; P K Shah; Y Shi; J H Haduong; Y A Declerck; Y Gabet; B Frenkel
Journal:  Osteoporos Int       Date:  2011-09-01       Impact factor: 4.507

5.  Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation.

Authors:  Gregory A Clines; Khalid S Mohammad; Yongde Bao; Owen W Stephens; Larry J Suva; John D Shaughnessy; Jay W Fox; John M Chirgwin; Theresa A Guise
Journal:  Mol Endocrinol       Date:  2006-10-26

6.  Identification of differentially expressed genes between osteoblasts and osteocytes.

Authors:  Frane Paic; John C Igwe; Ravi Nori; Mark S Kronenberg; Tiziana Franceschetti; Patrick Harrington; Lynn Kuo; Dong-Guk Shin; David W Rowe; Stephen E Harris; Ivo Kalajzic
Journal:  Bone       Date:  2009-06-17       Impact factor: 4.398

7.  Runx2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation.

Authors:  Luke H Hoeppner; Frank Secreto; Eric D Jensen; Xiaodong Li; Rachel A Kahler; Jennifer J Westendorf
Journal:  J Cell Physiol       Date:  2009-11       Impact factor: 6.384

8.  Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein.

Authors:  Marcin Kowanetz; Ulrich Valcourt; Rosita Bergström; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

9.  Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signalling.

Authors:  Blair Hopwood; Anna Tsykin; David M Findlay; Nicola L Fazzalari
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 10.  Genomic approaches to identifying transcriptional regulators of osteoblast differentiation.

Authors:  Joseph P Stains; Roberto Civitelli
Journal:  Genome Biol       Date:  2003-07-01       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.